VDBP has not previously been reported as an ovarian cancer marker, although using a peptide profiling approach, endogenous proteolytic fragments of VDBP were identified in ascites fluid from ovarian cancer patients, but not from control patients with liver cirrhosis 33. The gene discussed is GC; the disease is ovarian carcinoma.